Pfizer (NYSE: PFE) is an interesting healthcare company with excellent prospects for cash flow growth. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 ...

We recently compiled a list of the 15 Stocks Targeted By Activist Hedge Funds. In this article, we are going to take a look ...

PFE's strong economic moat is threatened by upcoming patent expirations, but its oncology segment shows promising growth ...

The pharma giant pulled out of its partnership with Sangamo, signalling unsteady waters for the latter company and the future ...

The markets have been red hot and many stocks may seem too expensive today. Still, there are some good deals out there to be ...

Pfizer gave Sangamo Therapeutics coal for Christmas, terminating a hemophilia A gene therapy pact to deprive the ...

We recently compiled a list of the Jim Cramer’s Bold Predictions About These 10 Healthcare Stocks. In this article, we are ...

ATLANTA — New provisions from Georgia election reform law Senate Bill 189 took effect Wednesday, focused on absentee ballot ...

Finbold asked ChatGPT which undervalued stocks of 2024 are worth tracking - and possibly investing in - in 2025.

Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS ...

Sangamo Therapeutics Inc.’s stock sank sharply on the last day of 2025 as Pfizer Inc. handed back the rights to their collaborative gene therapy hemophilia A program. While it was another big loss to ...

Sangamo, a gene therapy pioneer, loses a financial lifeline as Pfizer drops a gene therapy program for hemophilia.